Home Newsfeeds Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.

byBenzinga Newsdesk

December 12, 2022

1 minute read

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.

Analysts Had Mixed Views On Adobe Post Annual Event

By Anusuya Lahiri

Yesterday, 2:59 PM

Analysts attended Adobe Inc's (NASDAQ: ADBE) annual creativity conference, MAX, and its financial analyst meeting yesterday.

ADBE

News
Tech

Advantage Qualcomm: World’s Largest Smartphone Maker Could Switch Completely To Snapdragon Chips For Its Next Flagship

By Ananya Gairola

June 18, 4:17 AM

Samsung's flagship phone Galaxy S25 is expected to feature Qualcomm's next-gen chipset exclusively, boosting its sales.

QCOM

Elon Musk’s Tesla Confronts ‘Black Cloud’: Q4 Earnings To Draw ‘Line In The Sand Around Margins,’ Analyst Says

By Neil Dennis

January 23, 1:06 PM

Tesla set to report Q4 earnings, investors focused on margin and demand outlook. Price cuts in 2023 helped demand, but can they continue? Wedbush maintains outperform rating and $350 PT. Short interest in stock has decreased. Uncertainty remains for EVs.

TSLA